These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6199466)
1. Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE). Lisak RP; Zweiman B; Blanchard N; Rorke LB J Neurol Sci; 1983 Dec; 62(1-3):281-93. PubMed ID: 6199466 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Teitelbaum D; Arnon R; Sela M Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3842-7. PubMed ID: 10097125 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700 [TBL] [Abstract][Full Text] [Related]
4. Human cellular immune response to copolymer I and myelin basic protein. Burns J; Krasner LJ; Guerrero F Neurology; 1986 Jan; 36(1):92-4. PubMed ID: 2417162 [TBL] [Abstract][Full Text] [Related]
5. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508 [TBL] [Abstract][Full Text] [Related]
6. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Aharoni R; Teitelbaum D; Sela M; Arnon R Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718 [TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis. Arnon R; Teitelbaum D; Sela M Isr J Med Sci; 1989 Dec; 25(12):686-9. PubMed ID: 2533187 [TBL] [Abstract][Full Text] [Related]
8. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence on disease production by encephalitogenic doses of myelin basic protein. Hosein ZZ; Gilbert JJ; Strejan GH J Neuroimmunol; 1986 Jan; 10(3):219-33. PubMed ID: 2416773 [TBL] [Abstract][Full Text] [Related]
9. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates. McKenna RM; Carter BG; Paterson JA; Sehon AH Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127 [TBL] [Abstract][Full Text] [Related]
10. Defective T helper cell epitope responsible for the failure of region 69-84 of the human myelin basic protein to induce experimental allergic encephalomyelitis in the Lewis rat. Hashim GA; Galang AB; Srinivasan JV; Carvalho EF; Offner H; Vandenbark AA; Cleveland WL; Day ED J Neurosci Res; 1989 Oct; 24(2):222-30. PubMed ID: 2479765 [TBL] [Abstract][Full Text] [Related]
11. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. Happ MP; Wettstein P; Dietzschold B; Heber-Katz E J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618 [TBL] [Abstract][Full Text] [Related]
12. Cop 1 as a candidate drug for multiple sclerosis. Teitelbaum D; Arnon R; Sela M J Neural Transm Suppl; 1997; 49():85-91. PubMed ID: 9266417 [TBL] [Abstract][Full Text] [Related]
13. Chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs: cell-mediated immunity and IgG isoelectric focusing in myelin basic protein-liposome-treated and untreated animals. St Louis J; Gilbert JJ; Moscarello MA; Strejan GH J Neuroimmunol; 1989 Feb; 21(2-3):137-47. PubMed ID: 2463997 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428 [TBL] [Abstract][Full Text] [Related]
15. Chronic experimental allergic encephalomyelitis in guinea pigs: immunologic studies on the two major myelin proteins. Cambi F; Lees MB Cell Immunol; 1984 Jul; 86(2):567-74. PubMed ID: 6203654 [TBL] [Abstract][Full Text] [Related]
16. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes. Hosein ZZ; Gilbert JJ; Strejan GH Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529 [TBL] [Abstract][Full Text] [Related]
17. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Mannie MD; Paterson PY; U'Prichard DC; Flouret G Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5515-9. PubMed ID: 3875098 [TBL] [Abstract][Full Text] [Related]
18. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. Arnon R; Sela M; Teitelbaum D J Neurol; 1996 Apr; 243(4 Suppl 1):S8-13. PubMed ID: 8965119 [TBL] [Abstract][Full Text] [Related]
19. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Skundric DS; Huston K; Shaw M; Tse HY; Raine CS Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038 [TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison. Strejan GH; St Louis J Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]